


Healthcare News Roundup: Regulatory
HSMN NewsFeed - 21 Feb 2014
Cordis Corporation Receives CE Mark for RENLANE(TM) Renal Denervation System to Treat Resistant Hypertension
Cordis Corporation Receives CE Mark for RENLANE(TM) Renal Denervation System to Treat Resistant Hypertension
HSMN NewsFeed - 20 Feb 2014
Cyberonics Announces CE Mark Approval Of The AspireSR(TM) Generator For VNS Therapy(R)
Cyberonics Announces CE Mark Approval Of The AspireSR(TM) Generator For VNS Therapy(R)
HSMN NewsFeed - 18 Feb 2014
New Smart Tool Approved by Health Canada for Enhancing Hip Replacement Surgery
New Smart Tool Approved by Health Canada for Enhancing Hip Replacement Surgery
HSMN NewsFeed - 29 Jan 2014
IsoRay Receives Five Year CE Mark Extension for All Cesium-131 Seed Products
IsoRay Receives Five Year CE Mark Extension for All Cesium-131 Seed Products
HSMN NewsFeed - 28 Jan 2014
Sapheon VenaSeal(R) Receives Health Canada Approval; First Cases Performed in Vancouver and Toronto
Sapheon VenaSeal(R) Receives Health Canada Approval; First Cases Performed in Vancouver and Toronto
HSMN NewsFeed - 22 Jan 2014
Bioject's Distributor Meditrend International Receives Australian Device Registration
Bioject's Distributor Meditrend International Receives Australian Device Registration
HSMN NewsFeed - 6 Jan 2014
PIXUVRI(R) (pixantrone) Receives Positive Final Appraisal Determination from NICE
PIXUVRI(R) (pixantrone) Receives Positive Final Appraisal Determination from NICE
HSMN NewsFeed - 3 Jan 2014
NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara(R) in Europe
NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara(R) in Europe
